This website shows clinical studies recruiting people with type 1 diabetes or their family members. It only includes type 1 diabetes clinical studies that are supported by the Special Diabetes Program. You can also search for studies by eligibility (e.g., patient, family member) or location (where you live).
To learn about additional type 1 diabetes clinical trials, please visit http://www.clinicaltrials.gov. The National Institute of Allergy and Infectious Diseases (NIAID) also sponsors clinical trials related to type 1 diabetes. Find out more about NIAID-supported type 1 diabetes studies.
Study Name |
Who Can Participate? |
---|---|
Type 1 Diabetes TrialNet | |
To participate in the screening phase of the Pathway to Prevention Study, you must be: In general, type 1 diabetes is assumed if it developed before age 40 and required insulin injections within a year of diagnosis. |
|
To be screened for the study, you must be: |
|
Anti-CD3 mAb for Prevention of Type 1 Diabetes in Relatives At Risk (Teplizumab) |
You can be screened for the study if: |
Search for Diabetes in Youth | |
Children and youth who are under age 20 when they were diagnosed with diabetes may be eligible to join. Eligibility may depend on the place the child or young adult resides or the place where health care is received. |
|
Clinical Islet Transplantation Consortium | |
In general, to participate in this study, one must be 18-68 years of age, diagnosed with type 1 diabetes before age 40, be insulin dependent for more than 5 years, and have received a kidney transplant. There are more specific inclusion and exclusion criterion for participation in this study, which can be discussed with the study contact. |
|
Islet Transplantation in Type 1 Diabetes with LEA29Y Maintenance Therapy (CIT-04) |
You may be enrolled into this study, if you: |
In general, to participate in this study, one must be 18-65 years of age, diagnosed with type 1 diabetes before age 40, and be insulin dependent for more than 5 years. There are more specific inclusion and exclusion criterion for participation in this study, which can be discussed with the study contact. |
For information on studies that are complete, or ongoing studies that are no longer
recruiting patients, please visit the following websites:
Clinical Islet Transplantation Consortium: www.citisletstudy.org/
Diabetes Research in Children Network: direcnet.jaeb.org
Diabetic Retinopathy Clinical Research Network: www.drcr.net
Epidemiology of Diabetes Interventions and Complications (EDIC): http://www2.bsc.gwu.edu/bsc/oneproj.php?pkey=10
Immune Tolerance Network: www.immunetolerance.org
The Environmental Determinants of Diabetes in the Young (TEDDY): www.teddystudy.org
Trial To Reduce IDDM in the Genetically At Risk (TRIGR): www.trigr.org
Type 1 Diabetes Genetics Consortium: www.t1dgc.org/home.cfm
Type 1 Diabetes TrialNet: www.diabetestrialnet.org